Enhancing blood fibrinolytic activity by a niacin compound 3. Study of the activation mechanism.
D001786:Blood Glucose / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D010100:Oxygen / Q000378:metabolism; D012110:Reserpine / Q000627:therapeutic use
D001786:Blood Glucose; D012110:Reserpine; D010100:Oxygen